Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Steve Bloch
AddedMar 31, 2024
UpdatedMay 31, 2026
Steve Bloch

Steve Bloch

Board Member, Truveris

Crunchbase

Steve Bloch's Career

Truveris
Truveris

New York City, NY, US

Board Member· Board
Axial Exchange
Axial Exchange

Raleigh, NC, US

Board Member· Board
Envisia Therapeutics
Envisia Therapeutics

Morrisville, NC, US

Board Member· Board
Corvium
Corvium

Reston, VA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Steve Bloch's Career

Truveris
Truveris
Series D$54M1792009New York City, NY, US
Board Member· Board

Leadership at Truveris

Marcia RadosevichMarcia RadosevichBoard Member
Matthew SimasMatthew SimasBoard Member
Sally WelbornSally WelbornBoard Member
Leon GreeneLeon GreeneBoard Member
Steve BrotmanSteve BrotmanBoard Member
A. J. LoiaconoA. J. LoiaconoCo-Founder
Axial Exchange
Axial Exchange
Investment FirmInvestment Firm$9.4M112009Raleigh, NC, US
Board Member· Board

Leadership at Axial Exchange

Joanne RohdeJoanne RohdeFounder
David CarneyDavid CarneyBoard Member
Envisia Therapeutics
Envisia Therapeutics
Acquired$46.1M02013Morrisville, NC, US
Board Member· Board

Leadership at Envisia Therapeutics

Ed MathersEd MathersBoard Member
Ben YerxaBen YerxaFounder
Adrienne GravesAdrienne GravesBoard Member
Gary M PhillipsGary M PhillipsBoard Member
William E YelleWilliam E YelleBoard Member

Similar to Envisia Therapeutics

VisioxVisioxTarrytown, NY, USTherapeuticsest. 2022VisioxTarrytown, NY, US · est. 2022

Visiox: A privately-funded biopharmaceutical firm innovating new treatments for prevalent ophthalmic diseases.

Seed · $7M7
Corvium
Corvium
Series A$35.9M2752009Reston, VA, US
Board Member· Board

Leadership at Corvium

Jeff SwartzJeff SwartzBoard Member
Timothy LuTimothy LuBoard Member
Tim CurranTim CurranBoard Member
Jeff BussgangJeff BussgangBoard Member
Micah RosenbloomMicah RosenbloomBoard Member
Michael KoerisMichael KoerisBoard Member

Similar to Corvium

SafetyChain SoftwareSafetyChain SoftwareNovato, CA, USFood Safety, Quality Assuranceest. 2011SafetyChain SoftwareNovato, CA, US · est. 2011

Cloud-based food safety and quality assurance solutions provider, SafetyChain Software, Inc.

Private Equity · $50M121
TraceGainsTraceGainsWestminster, CO, USFood Safety, Softwareest. 2008TraceGainsWestminster, CO, US · est. 2008

Tracegains Inc: A US-based software company enhancing food safety and quality with innovative technology.

Series A · $6M138
PheniumPheniumSan Francisco, CA, USFood Safetyest. 2016PheniumSan Francisco, CA, US · est. 2016

Phenium: Automated Food-Safety-as-a-Service using technology and behavioral science.

Seed · $647k5

Steve Bloch's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · Kakao

People Similar to Steve Bloch

Joseph CostelloJoseph CostelloCo-Founder · Telo TherapeuticsSteven MetzgerSteven MetzgerFounder · Accelerate DiagnosticsEric ChinEric ChinBoard Member · ScriptedScott DublinScott DublinCo-Founder · Radiance TechnologiesScott SlaterScott SlaterCo-Founder · FrequenczGeorge ClarkGeorge ClarkCo-Founder · Radiance Technologies